Sells hemp-derived wellness supplements, beverages and pet products to consumers, retailers and distributors.
10-K for FY2025, filed Dec 19, 2025cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by…View ↗
We operate a multi-brand portfolio anchored by our flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals…View ↗
Our Herbal Oasis (“Oasis”) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to…View ↗
Our products are sold through a diversified distribution network that includes direct-to-consumer e-commerce platforms, online…View ↗
Consumers typically pay before products ship for online and telephone orders. Wholesale customers generally pay within 30 days after the products are transferred to them, though payment terms vary.
10-K for FY2025, filed Dec 19, 2025
$19.2M
10-K for FY2025, filed Dec 19, 2025
$19.2M ↗
Consumers buy through the company’s websites and telephone channel; retailers and wholesale distributors buy products for resale, with inside sales reaching specialty retailers and distributors.
10-K for FY2025, filed Dec 19, 2025We distribute our products both through our online sales channel as well as through a number of wholesalers and retailers that resell our…View ↗
E-commerce sales - consumer products sold through the Company’s online and telephonic channels. Revenue is recognized when control of the…View ↗
Wholesale sales - products sold to the Company’s wholesale customers for subsequent resale. Revenue is recognized when control of the goods…View ↗
No. It lost $2M in FY2025.
10-K for FY2025, filed Dec 19, 2025
−$2.2MView ↗
10-K for FY2025, filed Dec 19, 2025
−$2MView ↗
10-K for FY2025, filed Dec 19, 2025
−$1.6MView ↗
10-Q for Q3 FY2026, filed Aug 13, 2026
−$1.1MView ↗
8-K, filed Sep 2, 2026
On September 1, 2026, cbdMD, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) by and among…View ↗
8-K, filed Jan 14, 2026
On January 12, 2026 (the “Closing”), cbdMD, Inc., a North Carolina corporation (the “Company”) and Gaia Botanicals, LLC, a Colorado limited…View ↗
Shrinking. Revenue fell 57% in 4 years, from $44.5M in FY2021 to $19.2M in FY2025, about 19% a year.
Broader product range
The brand lineup has expanded beyond CBD and pet products to include functional mushroom supplements and hemp-derived THC beverages.
10-K for FY2022, filed Dec 15, 2022 10-K for FY2025, filed Dec 19, 2025We own and operate the nationally recognized CBD (cannabidiol) brands cbdMD, Paw CBD and cbdMD Botanicals. We believe that we are an…View ↗
Our cbdMD brand of products includes an array of high-grade, premium every day and functional CBD products, including tinctures; gummies…View ↗
Our Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying…View ↗
We operate a multi-brand portfolio anchored by our flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals…View ↗
Our ATRX® platform offers cutting edge, emerging and novel non-cannabinoid functional ingredients such as functional mushrooms and supports…View ↗
Our Herbal Oasis (“Oasis”) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to…View ↗
Manufacturing model
Production has shifted from fully outsourced manufacturing to a hybrid setup with some in-house production and third-party manufacturers.
10-K for FY2022, filed Dec 15, 2022 10-K for FY2025, filed Dec 19, 2025During 2022 the Company completed the sale of its manufacturing assets to Steady State, LLC, significantly reducing its fixed overhead…View ↗
cbdMD’s manufacturing, supply chain, and quality systems are designed to support rigorous standards of quality, safety, consistency, and…View ↗
Loading...